Revenio Group Corporation (REG1V) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Revenio Group Corporation (REG1V) has a cash flow conversion efficiency ratio of 0.064x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€6.70 Million ≈ $7.83 Million USD) by net assets (€104.40 Million ≈ $122.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Revenio Group Corporation - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Revenio Group Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Revenio Group Corporation debt and liabilities for a breakdown of total debt and financial obligations.
Revenio Group Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Revenio Group Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chongqing Machinery & Electric Co. Ltd
F:CE3
|
0.001x |
|
NationGate Holdings Berhad
KLSE:0270
|
0.091x |
|
Symtek Automation Asia Co Ltd
TW:6438
|
0.008x |
|
Perfect Group Corp Ltd Class A
SHG:603059
|
0.048x |
|
Zaptec AS
OL:ZAP
|
0.579x |
|
Shanxi Yongdong Chemistry Industry Co Ltd
SHE:002753
|
0.000x |
|
Aerostar Bacau
RO:ARS
|
N/A |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
F:GU5
|
0.050x |
Annual Cash Flow Conversion Efficiency for Revenio Group Corporation (2001–2024)
The table below shows the annual cash flow conversion efficiency of Revenio Group Corporation from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see REG1V stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €107.71 Million ≈ $125.92 Million |
€23.87 Million ≈ $27.91 Million |
0.222x | +103.85% |
| 2023-12-31 | €99.89 Million ≈ $116.79 Million |
€10.86 Million ≈ $12.70 Million |
0.109x | -57.46% |
| 2022-12-31 | €90.92 Million ≈ $106.29 Million |
€23.24 Million ≈ $27.17 Million |
0.256x | -6.79% |
| 2021-12-31 | €78.43 Million ≈ $91.69 Million |
€21.51 Million ≈ $25.15 Million |
0.274x | +25.52% |
| 2020-12-31 | €69.71 Million ≈ $81.50 Million |
€15.23 Million ≈ $17.81 Million |
0.218x | +12.60% |
| 2019-12-31 | €64.36 Million ≈ $75.25 Million |
€12.49 Million ≈ $14.60 Million |
0.194x | -66.34% |
| 2018-12-31 | €18.07 Million ≈ $21.13 Million |
€10.42 Million ≈ $12.18 Million |
0.576x | +17.09% |
| 2017-12-31 | €15.99 Million ≈ $18.69 Million |
€7.87 Million ≈ $9.20 Million |
0.492x | +21.86% |
| 2016-12-31 | €14.97 Million ≈ $17.50 Million |
€6.05 Million ≈ $7.07 Million |
0.404x | -10.85% |
| 2015-12-31 | €15.03 Million ≈ $17.58 Million |
€6.81 Million ≈ $7.96 Million |
0.453x | +97.77% |
| 2014-12-31 | €12.06 Million ≈ $14.10 Million |
€2.76 Million ≈ $3.23 Million |
0.229x | -37.51% |
| 2013-12-31 | €14.96 Million ≈ $17.49 Million |
€5.48 Million ≈ $6.41 Million |
0.367x | +595.09% |
| 2012-12-31 | €14.68 Million ≈ $17.16 Million |
€774.00K ≈ $904.89K |
0.053x | -79.51% |
| 2011-12-31 | €16.43 Million ≈ $19.20 Million |
€4.23 Million ≈ $4.94 Million |
0.257x | +193.03% |
| 2010-12-31 | €14.50 Million ≈ $16.95 Million |
€1.27 Million ≈ $1.49 Million |
0.088x | -29.30% |
| 2009-12-31 | €15.74 Million ≈ $18.40 Million |
€1.96 Million ≈ $2.29 Million |
0.124x | -33.34% |
| 2008-12-31 | €17.59 Million ≈ $20.56 Million |
€3.28 Million ≈ $3.83 Million |
0.186x | +25.09% |
| 2007-12-31 | €22.22 Million ≈ $25.98 Million |
€3.31 Million ≈ $3.87 Million |
0.149x | +163.43% |
| 2006-12-31 | €10.96 Million ≈ $12.81 Million |
€620.00K ≈ $724.85K |
0.057x | -71.65% |
| 2005-12-31 | €5.02 Million ≈ $5.87 Million |
€1.00 Million ≈ $1.17 Million |
0.200x | +332.85% |
| 2004-12-31 | €2.16 Million ≈ $2.52 Million |
€-184.78K ≈ $-216.03K |
-0.086x | +84.26% |
| 2003-12-31 | €1.10 Million ≈ $1.29 Million |
€-600.19K ≈ $-701.68K |
-0.545x | +39.72% |
| 2002-12-31 | €4.32 Million ≈ $5.05 Million |
€-3.90 Million ≈ $-4.56 Million |
-0.903x | -4584.91% |
| 2001-09-30 | €17.72 Million ≈ $20.72 Million |
€357.00K ≈ $417.37K |
0.020x | -- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pre… Read more